Sign in
8-K

Current Report

Calidi Biotherapeutics, Inc. Filed Acc 0001493152-23-038596

Material agreement · Executive or director change · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading form8-k.htm…